by WRAL TechWire — May 14, 2021 . MORRISVILLE – New funding in the form of $7 million in A Series B fROUND will accelerate the commercialization of the automated and individualized poultry vaccination systems, SAYS Morrisville-based Applied LifeSciences & Systems, or ALSS. The round was co-led by Merck Animal Health and Mountain Group Partners, and included an investment from Oval Park Capital, a Raleigh-based early-stage investment firm, which was also an early investor. According to the company, its high-speed imaging, feature recognition, artificial intelligence, robotics, and microfluidics proprietary technologies are integrated in a system developed to address a significant challenge for the commercial poultry industry: successful, efficient vaccinations.